CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $217,000 | -90.6% | 107,645 | -51.1% | 0.00% | -100.0% |
| Q4 2019 | $2,297,000 | +437.9% | 220,317 | +102.7% | 0.01% | +600.0% |
| Q3 2019 | $427,000 | -79.4% | 108,692 | -22.0% | 0.00% | -85.7% |
| Q2 2019 | $2,072,000 | -40.2% | 139,350 | -0.1% | 0.01% | -41.7% |
| Q1 2019 | $3,464,000 | +39.7% | 139,550 | +1.1% | 0.01% | +20.0% |
| Q4 2018 | $2,479,000 | -4.3% | 138,037 | +56.5% | 0.01% | 0.0% |
| Q3 2018 | $2,590,000 | -28.1% | 88,177 | +11.4% | 0.01% | -28.6% |
| Q2 2018 | $3,600,000 | -15.3% | 79,177 | -1.6% | 0.01% | -17.6% |
| Q1 2018 | $4,249,000 | +0.2% | 80,477 | +29.0% | 0.02% | -5.6% |
| Q4 2017 | $4,242,000 | -20.6% | 62,382 | -3.8% | 0.02% | -28.0% |
| Q3 2017 | $5,343,000 | +182.4% | 64,844 | +187.8% | 0.02% | +177.8% |
| Q2 2017 | $1,892,000 | +240.9% | 22,528 | +158.4% | 0.01% | +200.0% |
| Q1 2017 | $555,000 | +43.8% | 8,719 | -1.7% | 0.00% | +50.0% |
| Q4 2016 | $386,000 | -8.1% | 8,874 | -23.7% | 0.00% | -33.3% |
| Q3 2016 | $420,000 | +1515.4% | 11,638 | +524.4% | 0.00% | – |
| Q2 2016 | $26,000 | +4.0% | 1,864 | +42.1% | 0.00% | – |
| Q1 2016 | $25,000 | – | 1,312 | +10833.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 12 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | -97.4% | 12 | -98.3% | 0.00% | – |
| Q4 2014 | $39,000 | +875.0% | 700 | +600.0% | 0.00% | – |
| Q2 2014 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |